These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38244566)

  • 1. Advanced considerations in survival analysis.
    Carnero-Alcázar M; Montero-Cruces L; Cobiella-Carnicer J; Pérez-Camargo D; Maroto Castellanos L
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38244566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.
    Hsu JY; Roy JA; Xie D; Yang W; Shou H; Anderson AH; Landis JR; Jepson C; Wolf M; Isakova T; Rahman M; Feldman HI;
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1181-1189. PubMed ID: 28242844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of gastric cancer survival: using an artificial hierarchical neural network.
    Amiri Z; Mohammad K; Mahmoudi M; Zeraati H; Fotouhi A
    Pak J Biol Sci; 2008 Apr; 11(8):1076-84. PubMed ID: 18819544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.
    Schuster NA; Hoogendijk EO; Kok AAL; Twisk JWR; Heymans MW
    J Clin Epidemiol; 2020 Jun; 122():42-48. PubMed ID: 32165133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
    Nolan EK; Chen HY
    Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaplan-Meier Survival, Actuarial Survival, Censoring, and Competing Events-What Is What?
    Hage A; Hage F
    Ann Thorac Surg; 2022 Jul; 114(1):40-43. PubMed ID: 35367199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.
    Beuscart JB; Pagniez D; Boulanger E; Lessore de Sainte Foy C; Salleron J; Frimat L; Duhamel A
    BMC Nephrol; 2012 May; 13():31. PubMed ID: 22646159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models.
    Mozumder SI; Rutherford MJ; Lambert PC
    BMC Med Res Methodol; 2021 Mar; 21(1):52. PubMed ID: 33706711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When do we need competing risks methods for survival analysis in nephrology?
    Noordzij M; Leffondré K; van Stralen KJ; Zoccali C; Dekker FW; Jager KJ
    Nephrol Dial Transplant; 2013 Nov; 28(11):2670-7. PubMed ID: 23975843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.
    Wei Y; Royston P; Tierney JF; Parmar MK
    Stat Med; 2015 Sep; 34(21):2881-98. PubMed ID: 26099573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of survival distributions in clinical trials: A practical guidance.
    Chen X; Wang X; Chen K; Zheng Y; Chappell RJ; Dey J
    Clin Trials; 2020 Oct; 17(5):507-521. PubMed ID: 32594788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
    J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Practical Overview and Reporting Strategies for Statistical Analysis of Survival Studies.
    Dey T; Mukherjee A; Chakraborty S
    Chest; 2020 Jul; 158(1S):S39-S48. PubMed ID: 32658651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical primer: basics of survival analysis for the cardiothoracic surgeon.
    Thuijs DJFM; Hickey GL; Osnabrugge RLJ
    Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):1-4. PubMed ID: 29800119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of random survival forests in understanding the determinants of under-five child mortality in Uganda in the presence of covariates that satisfy the proportional and non-proportional hazards assumption.
    Nasejje JB; Mwambi H
    BMC Res Notes; 2017 Sep; 10(1):459. PubMed ID: 28882171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
    Tai BC; Machin D; White I; Gebski V;
    Stat Med; 2001 Mar; 20(5):661-84. PubMed ID: 11241570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.
    Zhao L; Tian L; Uno H; Solomon SD; Pfeffer MA; Schindler JS; Wei LJ
    Clin Trials; 2012 Oct; 9(5):570-7. PubMed ID: 22914867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression models for the restricted residual mean life for right-censored and left-truncated data.
    Cortese G; Holmboe SA; Scheike TH
    Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.